STX-107

SynDRA canonical compound SYN1957269 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	GRM5
Mechanism of action	glutamate metabotropic receptor antagonist
Indication	parkinson's disease
Disease area	Neurology

All known targets

GRM5

Mechanisms of action (all sources)

GRM5 ANTAGONIST

Cross-references

PubChem CID: 16662948
TTD: D09YDQ

Synonyms

2-Methyl-4-(pyridin-3-ylethynyl)thiazole
MTEP
mGluR5 Antagonist, MTEP
CHEMBL292065
3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine
3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine
3-[2-(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine
3-(2-(2-methylthiazol-4-yl)ethynyl)pyridine
3-[2-(2-Methylthiazol-4-yl)ethynyl]pyridine
3-(2-Methyl-thiazol-4-ylethynyl)-pyridine
SCHEMBL187254
GTPL3336
CTK1B8867
DTXSID30430775
ZINC1489321
IN1238
BDBM50122758
FCH3417361
API0006876
ACN-027361
KB-274670

Look up STX-107 in the interactive SynDRA portal →